Medicare Enrolled

Dr. Eleonora Lad, MD, PHD

Optician · Durham, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
121 CRIMSON OAK DR, Durham, NC 27713
6507968526
In practice since 2008 (18 years)
NPI: 1811150576 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lad

Dr. Eleonora Lad is an optician specialist in Durham, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lad performed 21,376 Medicare services across 1,462 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lad received a total of $242,952 from 17 pharmaceutical and/or device companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 3% volume in NC $242,952 industry payments

Medicare Practice Summary

Medicare Utilization ↗
21,376
Medicare services
Top 3% in NC for optician
1,462
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,188 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
17,520 $29 $72
Aflibercept eye injection (Eylea) 948 $686 $1,442
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
772 $87 $291
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
716 $94 $1,110
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
636 $28 $172
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
316 $17 $99
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
255 $27 $189
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
89 $55 $150
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
60 $83 $488
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
29 $11 $63
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
19 $1,951 $4,365
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
16 $85 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$242,952
Total received (2018-2024)
Avg $34,707/year across 7 years
Top 1% in NC for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
116
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$229,685 (94.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,829 (5.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$438 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$98,274
2023
$30,154
2022
$64,345
2021
$12,862
2020
$16,785
2019
$10,481
2018
$10,051

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim International GmbH
$37,518
Astellas Pharma Global Development
$35,850
Ocular Therapeutix, Inc.
$11,044
Apellis Pharmaceuticals, Inc.
$7,074
Alcon Research LLC
$2,148
Regeneron Pharmaceuticals, Inc.
$1,880
Astellas Pharma US Inc
$1,650
Janssen Global Services, LLC
$1,110
Top 3 companies account for 85.9% of 2024 payments
All-time payments by company (2018-2024) ›
Apellis Pharmaceuticals, Inc.
$40,917
Astellas Pharma Global Development
$39,950
Boehringer Ingelheim International GmbH
$37,518
F. Hoffmann-La Roche AG
$20,186
Genentech, Inc.
$17,013
Alexion Pharmaceuticals, Inc.
$16,352
Janssen Global Services, LLC
$16,087
Janssen Research & Development, LLC
$15,800
Boehringer Ingelheim Pharmaceuticals, Inc.
$11,052
Ocular Therapeutix, Inc.
$11,044
Novartis Pharmaceuticals Corporation
$8,126
Regeneron Pharmaceuticals, Inc.
$4,858
Alcon Research LLC
$2,148
Astellas Pharma US Inc
$1,650
NotalVision
$128
Allergan Inc.
$90
ABBVIE INC.
$34
Top 3 companies account for 48.7% of all-time payments
Associated products mentioned in payments ›
AIR OPTIX · BEOVU · DEXTENZA · EYLEA · EYLEA HD · ForeseeHome · Izervay · Lucentis · Non-Covered Product · OZURDEX · SUSVIMO · Syfovre · VEOPOZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for optician in NC.

Looking for an optician specialist in Durham?
Compare opticians in the Durham area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
233
Per 100K population
70.7
County median income
$79,501
Nearest hospital
UNC HOSPITALS
8.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lad is a mixed practice specialist, with above-average Medicare volume (top 3% in NC), with consulting-driven industry engagement in the top 1% of NC peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lad experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Lad performed 17,520 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lad receive payments from pharmaceutical companies?
Yes. Dr. Lad received a total of $242,952 from 17 companies across 116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lad's costs compare to other opticians in Durham?
Dr. Lad's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →